OTC : CHGCY

Chugai Pharmaceutical Co., Ltd. — Earnings Estimates

$22.22 USD

$0.56 (2.59%)

Volume
74.9K
Average Volume
273.38K
Market Capitalization
$73.14B
P/E Ratio
24.83
Dividend Yield
2.99%
Price Target
Year High
$34.84
Year Low
$20.00
Day High
Day Low
Payout Ratio
$0.95
Current Ratio
$4.35

Annual earnings financials

CHGCY financial data with annual/quarterly toggle

CHGCY GAAP EPS - Annual & Quarterly

CHGCY Sales Revenue - Annual & Quarterly

CHGCY Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

CHGCY Estimated and Actual Revenue by Quarter
CHGCY Estimated and Actual EPS by Quarter
CHGCY Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2026-12-30 3 172.99B 179.84B 176.62B 162.72B 169.17B 166.14B
2026-09-30 3 159.9B 166.24B 163.26B 150.42B 156.38B 153.58B
2026-06-30 4 172.99B 179.84B 176.62B 162.72B 169.17B 166.14B
2026-03-31 9 130.99B 158.81B 144.14B 123.22B 149.39B 135.59B
2025-12-31 6 134.79B 166.89B 149.08B 126.79B 156.99B 140.24B
2025-09-30 7 140.25B 169.64B 154.38B 131.93B 159.58B 145.22B
CHGCY Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2026-12-30 3 - - - 34.84B 36.22B 35.57B
2026-09-30 3 - - - 32.2B 33.48B 32.88B
2026-06-30 4 - - - 34.84B 36.22B 35.57B
2026-03-31 9 - - - 26.38B 31.98B 29.03B
2025-12-31 6 - - - 27.14B 33.61B 30.02B
2025-09-30 7 - - - 28.24B 34.16B 31.09B
CHGCY Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2026-12-30 3 373.73B 388.54B 381.58B 0 0 0 0
2026-09-30 3 345.46B 359.15B 352.72B 0 0 0 0
2026-06-30 4 373.73B 388.54B 381.58B 0 0 0 0
2026-03-31 9 283B 343.1B 311.41B 0 0 0 0
2025-12-31 6 291.2B 360.56B 322.08B 0 0 0 0
2025-09-30 7 303B 366.5B 333.52B 0 0 0 0